Journals / Troia Tıp Dergisi / 2026 / Cilt: 7 Sayı: 3

Awareness level and factors affecting vaccine preference among individuals who received COVID-19 vaccination

COVID-19 aşısı yaptıran bireylerde farkındalık düzeyi ve aşı tercihini etkileyen faktörler

Gizem Özçelik Kaplan(Konya Numune Hastanesi, Aile Hekimliği)0000-0001-9202-2765
Duygu İlke Yıldırım(Selçuk Üniversitesi Tıp Fakültesi, Aile Hekimliği Anabilim Dalı)0000-0002-3893-5173
Merve Uğraş(SELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, AİLE HEKİMLİĞİ ANABİLİM DALI)0000-0002-6034-6172
Pages
139–145
Publication Date
2026-09-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As the sample comprised individuals attending a vaccination clinic, findings should not be generalised to unvaccina-ted populations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to evaluate factors affecting vaccine awareness and vaccine preferences in patients attending a COVID-19 vaccination outpatient clinic.
📊
Key Findings & Data:Methods: This cross-sectional study was conducted with 404 volunteer participants aged 18 years or older who attended the COVID-19 vaccination outpatient clinic at Konya City Hospital between 25 Au-gust and 25 October 2021.
💡
Conclusion & Impact:As the sample comprised individuals attending a vaccination clinic, findings should not be generalised to unvaccina-ted populations.
🔬Design:Survey & Empirical Study
📍Scope:2021 Verileri
⚙️Variables:COVID-19 Aşıları · Sağlık Okuryazarlığı · Hasta Tercihi

Abstract

Objective: This study aimed to evaluate factors affecting vaccine awareness and vaccine preferences in patients attending a COVID-19 vaccination outpatient clinic. Methods: This cross-sectional study was conducted with 404 volunteer participants aged 18 years or older who attended the COVID-19 vaccination outpatient clinic at Konya City Hospital between 25 Au-gust and 25 October 2021. Data were collected through face-to-face interviews using a sociodemographic information form, a COVID-19 vaccine knowledge and attitude questionnaire, and the COVID-19 Vaccine Literacy Scale (VLS). SPSS 18.0 was used for statistical analyses; p<0.05 was considered statistically significant. Results: Of the participants, 52% were female with a mean age of 32.54±11.24 years. All participants had been vaccinated; 69.8% chose the Pfizer-BioNTech mRNA vaccine. Perceived efficacy (73.5%) was the main determinant of vaccine preference. Individuals without chronic disease preferred Pfizer-BioNTech significantly more (p<0.001). In multivariate logistic regression, female sex (OR=1.881; 95% CI: 1.078–3.281) and chronic disease (OR=2.647; 95% CI: 1.440–4.798) were independent predictors of receiving more than two doses. The mean VLS total score was moderate (women: 2.83±0.49; men: 2.74±0.54) and was significantly higher among healthcare workers and university graduates (p<0.001). A significant negative correlation was found between age and the VLS total score (r=−0.110; p=0.027). Conclusion: Vaccine literacy was moderate and shaped mainly by education, occupation and information sources. Interventions to improve health literacy should be planned; healthcare providers, particu-larly general practitioners, should play a more active role in vaccine communication. As the sample comprised individuals attending a vaccination clinic, findings should not be generalised to unvaccina-ted populations.

Özet

Amaç: Bu çalışmanın amacı, COVID-19 aşı polikliniğine başvuran hastalarda aşı farkındalığını ve aşı tercihlerinde etkili olan faktörleri değerlendirmektir. Gereç ve Yöntem: Kesitsel nitelikteki bu çalışma, 25 Ağustos–25 Ekim 2021 tarihleri arasında Konya Şehir Hastanesi COVID-19 aşı polikliniğine başvuran 18 yaş ve üzeri 404 gönüllü katılımcı ile yürü-tülmüştür. Veriler; sosyodemografik bilgi formu, COVID-19 aşı bilgi ve tutum soru formu ile COVID-19 Aşı Okuryazarlığı Ölçeği (AOÖ) aracılığıyla yüz yüze görüşme yöntemiyle toplanmıştır. İstatistiksel analizlerde SPSS 18.0 kullanılmış, p<0.05 anlamlı kabul edilmiştir. Bulgular: Katılımcıların %52’si kadın, yaş ortalaması 32.54±11.24 yıldır. Tümü aşılanmış olan katılım-cıların %69.8’i Pfizer-BioNTech mRNA aşısını tercih etmiştir. Aşı tercihinde en belirleyici etken aşının etkinliğine duyulan güven (%73.5) olmuştur. Kronik hastalığı olmayan bireyler Pfizer-BioNTech’i an-lamlı düzeyde daha fazla tercih etmiştir (p<0.001). Çok değişkenli lojistik regresyon analizinde; kadın cinsiyeti (OR=1.881; %95 GA: 1.078–3.281) ve kronik hastalık varlığı (OR=2.647; %95 GA: 1.440–4.798) iki dozdan fazla aşılanmanın bağımsız prediktörleri olarak belirlenmiştir. COVID-19 AOÖ toplam puan ortalaması orta düzeyde saptanmış (kadın: 2.83±0.49; erkek: 2.74±0.54) olup sağlık çalışanları ve üniversite mezunlarında anlamlı olarak yüksek bulunmuştur (p<0.001). Yaş ile AOÖ toplam skoru ara-sında negatif yönde anlamlı korelasyon tespit edilmiştir (r=−0.110; p=0.027). Sonuç: Bireylerin aşı okuryazarlık düzeyleri orta düzeyde olup eğitim seviyesi, meslek ve bilgi kaynak-ları bu düzeyi şekillendiren başlıca faktörlerdir. Toplumun aşıya erişim ve kabulünü artırmak için sağlık okuryazarlığını güçlendirmeye yönelik müdahaleler planlanmalı; başta aile hekimleri olmak üzere sağlık hizmeti sunucuları aşı iletişiminde daha etkin rol üstlenmelidir. Örneklem aşı polikliniğine kendi isteğiyle başvurarak aşılanan bireylerden oluştuğundan, bulgular aşılanmamış kesime genellenmemelidir.

🔖

Cite This Article

Kaplan, G. Ö., Yıldırım, D. İ., Uğraş, M. (2026). Awareness level and factors affecting vaccine preference among individuals who received COVID-19 vaccination. Troia Tıp Dergisi, Cilt: 7 Sayı: 3, 139–145. https://doi.org/10.55665/troiamedj.1976292

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (26)

  1. Ahn DG, Shin HJ, Kim MH, et al. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol. 2020;30(3):313-324. doi: 10.4014/jmb.2003.03011.
  2. Anderson RM, Heesterbeek H, Klinkenberg D, et al. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395(10228):931-934. doi: 10.1016/S0140-6736(20)30567-5.
  3. Yavuz E. COVID-19 Vaccines. Türkiye Aile Hekimliği Dergisi. 2020;24(4):223-234. doi: 10.15511/tahd.20.00427.
  4. World Health Organization. Ten threats to global health in 2019. Geneva: WHO; 2019. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (Erişim tarihi: 31.08.2026).
  5. MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33(34):4161-4164. doi: 10.1016/j.vaccine.2015.04.036.
  6. Lazarus JV, Wyka K, White TM, et al. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat Med. 2023;29(2):366-375. doi: 10.1038/s41591-022-02185-4.
  7. Salali GD, Uysal MS. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol Med. 2022;52(15):3750-3752. doi: 10.1017/S0033291720004067.
  8. Ratzan SC. Vaccine literacy: a new shot for advancing health. J Health Commun. 2011;16(3):227-229. doi: 10.1080/10810730.2011.561726.
  9. Biasio LR, Bonaccorsi G, Lorini C, et al. Assessing COVID-19 vaccine literacy: A preliminary online survey. Hum Vaccin Immunother. 2021;17(5):1304-1312. doi: 10.1080/21645515.2020.1829315.
  10. Gusar I, Konjevoda S, Babić G, et al. Pre-vaccination COVID-19 vaccine literacy in a Croatian adult population: A cross-sectional study. Int J Environ Res Public Health. 2021;18(13):7073. doi: 10.3390/ijerph18137073.
  11. Costantini H. COVID-19 vaccine literacy of family carers for their older parents in Japan. Healthcare (Basel). 2021;9(8):1038. doi: 10.3390/healthcare9081038.
  12. Yüksekol ÖD, Baltaci N, Nazik F, et al. COVID-19 vaccine literacy levels among women of reproductive age. Journal of İnönü University Vocational School of Health Services. 2022;10(2):641-651. doi: 10.33715/inonusaglik.1020271.
  13. Biasio LR, Lorini C, Zanobini P, et al. COVID-19 vaccine literacy: a scoping review. Hum Vaccin Immunother. 2023;19(1):2176083. doi: 10.1080/21645515.2023.2176083.
  14. T.C. Sağlık Bakanlığı. COVID-19 Aşısı Ulusal Uygulama Stratejisi. Ankara: T.C. Sağlık Bakanlığı; 2021. https://covid19asi.saglik.gov.tr (Erişim tarihi: 31.08.2026).
  15. Ishikawa H, Takeuchi T, Yano E. Measuring functional, communicative, and critical health literacy among diabetic patients. Diabetes Care. 2008;31(5):874-879. doi: 10.2337/dc07-1932.
  16. Durmuş A, Akbolat M, Amarat M. Validity and reliability of the COVID-19 Vaccine Literacy Scale in Turkish. Cukurova Med J. 2021;46(2):732-741. doi: 10.17826/cumj.870432.
  17. Yılmaz Hİ, Turğut B, Çıtlak G, et al. Public attitudes towards the COVID-19 vaccine in Turkey. Dicle Medical Journal. 2021;48(3):583-594. doi: 10.5798/dicletip.988080.
  18. Latkin CA, Dayton L, Yi G, et al. Trust in a COVID-19 vaccine in the US: A social-ecological perspective. Soc Sci Med. 2021;270:113684. doi: 10.1016/j.socscimed.2021.113684.
  19. Rotshild V, Hirsh-Raccah B, Miskin I, et al. Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis. Sci Rep. 2021;11(1):22777. doi: 10.1038/s41598-021-02321-z.
  20. Dror AA, Eisenbach N, Taiber S, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775-779. doi: 10.1007/s10654-020-00671-y.
  21. Gencer N. Individuals’ fear of coronavirus (COVID-19) during the pandemic: The case of Çorum. Uluslararası Sosyal Bilimler Akademi Dergisi. 2020;(4):1153-1173. doi: 10.47994/usbad.791577.
  22. Ozisik L, Tanriover MD, Rigby S, et al. ADVICE for a healthier life: Adult Vaccination Campaign in Europe. Eur J Intern Med. 2016;33:14-20. doi: 10.1016/j.ejim.2016.04.021.
  23. Smith BA, Ricotta EE, Kwan JL, et al. COVID-19 risk perception and vaccine acceptance in individuals with self-reported chronic respiratory or autoimmune conditions. Allergy Asthma Clin Immunol. 2023;19(1):37. doi: 10.1186/s13223-023-00791-6.
  24. Toshkov D. Explaining the gender gap in COVID-19 vaccination attitudes. Eur J Public Health. 2023;33(3):490-495. doi: 10.1093/eurpub/ckad052.
  25. Darbandi M, Mahjub H, Poorolajal J, et al. Acceptance and hesitancy regarding COVID-19 vaccination and factors influencing them in adults: A systematic review. Immun Inflamm Dis. 2024;12(11):e70076. doi: 10.1002/iid3.70076.
  26. Pierz AJ, Rauh L, Masoud D, et al. Supporting US healthcare providers for successful vaccine communication. BMC Health Serv Res. 2023;23(1):423. doi: 10.1186/s12913-023-09348-0.